SEMINAR: Xiao-Fan Wang (Duke University)
August 22, 2018
UNC Lineberger team finds possible strategy to overcome radiation therapy resistance acquired by cancer cells
July 6, 2015
In a new study published in the Cell Press journal “Chemistry & Biology”, researchers in the Chen lab share a discovery that could lead to a new strategy for sensitizing radiation-resistant cancer cells to the treatment.
SEMINAR: Jun Qin, PhD (Baylor, College of Medicine)
July 3, 2014
“Proteomics and Precision Medicine”
SEMINAR: Neil Kelleher, PhD (Northwestern University)
July 3, 2014
“Top Down Proteomics for Precise Description of KRAS Gene Products in Colorectal Cancer”
National Cancer Institute-funded center to study proteins for better cancer diagnosis, treatment
September 26, 2011
The University of North Carolina at Chapel Hill, Washington University School of Medicine in St. Louis, and Boise State University have been named partners in one of five US centers that will use genetic data to search for proteins that are abnormally made by cancer cells. The partnerships form the new Clinical Proteomic Tumor Analysis Consortium (CPTAC) supported by the National Cancer Institute (NCI).
Department History
January 31, 2008
This section began with information courtesy of Dr. Thomas Traut in 2008. The Department of Biological Chemistry became an independent academic unit in 1935. In the earlier years of the twentieth century, the subject of biochemistry had been taught at UNC-Chapel Hill by professors holding an appointment within the Department of Physiology. Before 1938, biochemistry … Read more
Study provides insights behind hyperactivation of key cell proliferation signal
April 23, 2019
In a study in Nature Communications, Pengda Liu, PhD, Shelton Earp, MD, and their collaborators reported discoveries about a key signaling pathway that can be hyperactive in kidney cancer.
Program Alumni
September 13, 2013